Beyond hazard ratios, investigators used restricted mean survival time (RMST) analysis to compare survival gains across trialed ICI combinations for mRCC.

Testosterone replacement therapy (TRT) is linked to a significantly lower risk of major CV events in men with secondary hypogonadism.

Researchers present consensus statement for core competencies to guide education for medical students on medical cannabis use.

Five diabetes subgroups possess specific comorbidity risk profiles, with SIRD and SIDD generally exhibiting the highest risks for kidney disease, myocardial infarction, and total mortality compared ...

Investigators compared PSA90 response between new users of apalutamide vs abiraterone for mCSPC using a large US cohort.

The absolute difference in cancer-specific survival for thermal ablation vs surgery for T1a RCC was just 1%. Cancer-specific survival among patients with stage T1a renal cell carcinoma (RCC) is ...

In risk groups defined by American Urologic Association criteria, recurrences were reported in 8.9% of patients of the low-risk group, 11% of patients in the intermediate-risk group, 22% of those in ...

MRI is the ideal imaging modality for initial evaluation and diagnosis of testicular cancer.

The addition of RARP to ADT significantly increased the rate of achieving radical level PSA levels (74.7% vs 38.3%; P <.001) and a shorter time to PSA nadir (2 vs 6 months; P <.001) compared with ADT ...

Once-weekly tirzepatide is associated with clinically relevant reductions in SUA levels over 72 weeks, largely driven by substantial weight loss.